周围血干细胞移植术。
从试验结果来看，脐带血干细胞移植是有希望的。
Results from cord blood stem cell transplants are promising.
数千份脐带血干细胞移植被用来治愈患有血液或免疫力疾病的孩子。
Thousands of successful umbilical cord blood stem cell transplants have already been carried out to treat children with severe blood conditions or immune disorders.
获得新免疫系统的方法就是将新成血干细胞移植到骨髓中产生全血细胞。
The way to get a new immune system is to transplant new blood-forming stem cells into the bone marrow, where they generate all the cells of the blood.
目的：观察脐血干细胞移植对帕金森病(PD)大鼠神经功能恢复的影响。
Aim: To explore the effect of human umbilical cord stem cell transplantation on neurological function recovery of PD rats.
这也就是为什么当我们出生后，胎盘及脐带血能够用作造血干细胞移植的来源。
That is why, after birth, placental and umbilical cord blood can be used as a source of stem cells for transplantation.
研究人员发现一种将新成血干细胞移植到小鼠骨髓中的途径可以有效的代替原免疫系统。
The researchers found a way to transplant new blood-forming stem cells into the bone marrow of mice, effectively replacing their immune systems.
异体造血干细胞移植骨髓和周边血干细胞收集之比较造血干细胞可收集自捐者的骨髓或是周边血。
Haemopoietic stem cells can be collected from a donor either as a bone marrow harvest or by peripheral blood collection.
近年来，脐血造血干细胞移植已广泛用于治疗儿童白血病、先天性免疫缺陷病、遗传性代谢病等方面。
Till now cord blood transplantation has been widely used in treating children leukemia, inborn immune deficiency, heritage metabolic disease and so on.
脐带血富含造血祖细胞，既可作为造血干细胞移植新的来源，又可用于骨髓抑制患者的临床输注，有广阔的应用前景。
The umbilical cord blood included much more hematopoietic progenitor cells. The umbilical cord blood provided new source for hematopoietic cells transplantation and t...
周围血干细胞移植可能会用到大剂量化疗药物，要输入先前采集的未成熟血细胞(干细胞)来代替患病和受损的骨髓细胞。
Peripheral blood stem cell transplantation involves using high-dose chemotherapy and transfusion of previously collected immature blood cells (stem cells) to replace diseased or damaged marrow.
白血病患者和进行外周血或骨髓造血干细胞移植的患者，由于自身缺乏巨细胞病毒抗体，给他们输注的成分血必须是巨细胞病毒抗体阴性的。
Patients with leukemia and those undergoing blood or marrow stem cell transplantation, who themselves have no antibodies to CMV, should receive blood components that are negative for CMV antibodies.
1980年，骨髓移植手术的外科医生RobertSackstein注意到少于5%的被移植的血干细胞能达到病人的骨髓靶细胞，于是他决定研究细胞是怎样移动的，跟随的是什么指示。
When Robert Sackstein was a bone-marrow-transplant surgeon in the 1980s, henoticed that fewer than 5 percent of the transplanted blood stem cells reachedtheir target in a patient's marrow.
通过采用双份脐血，几乎所有的患者都可以寻找到移植所需的干细胞来源。
By using two UCB units, nearly all patients can now use this stem cell source for transplantation.
无论采用来自于外周血、骨髓或者脐血的干细胞进行移植，疾病的复发率都类似。
The relapse or disease recurrence rates are similar regardless of whether the stem cells used for transplantation are from bone marrow, peripheral blood, or umbilical cord blood.
捐赠的细胞来自于患者的兄弟姐妹，研究者从其中萃取极为特殊的CD 34血干细胞并移植到患者身上，该干细胞可以长成所有类型的血细胞。
The donated cells came from siblings, and the researchers extracted and transplanted very specific CD34 blood stem cells, which grow into all blood types.
六个研究（807位捐者）被纳入：全部皆是骨髓或周边血干细胞异体移植之随机对照试验的次分析或是部份组成。
Six trials (807 donors) were eligible: all were substudies, or constituent parts of, larger randomised controlled trials of bone marrow and peripheral blood stem cell allogeneic transplantation.
目的建立无关供者脐血干细胞库，用于治疗骨髓衰竭、恶性及非恶性血液病、某些遗传病、重型免疫缺陷等疾病的干细胞移植。
Objective To establish unrelated cord blood stem cell bank for providing potential grafts for stem cell transplantation in the treatment of some malignant and nonmalignant disorders.
捐赠脐带血和捐赠骨髓不一样，移植干细胞不需要寻找配对，所以有更多白血病和其他疾病的患者可以获救。
Placental blood donations differ from bone marrow donations, in that stem cells can be transplanted without the need to find a match. Thus more patients with leukemia and other diseases can be saved.
结论脐血间质干细胞移植治疗可以显著改善ALS患者的神经系统功能。
Conclusion: the transplantation of umbilical cord blood MSCs on ALS patients can improve their nervous system function significantly.
脐带血干细胞的保存及脐带血移植等临床应用均取得了显著的进展，但也面临许多问题。
The preservation of cord blood stem cells and umbilical cord blood transplantation, and other clinical applications have made significant progress, but blood is also facing many problems.
结论：经皮腔冠状动脉内移植骨髓干细胞治疗缺血性心肌病可行，术后能提高左室射血分数，心功能改善。
CONCLUSION: It is feasible to treat ischemic cardiomyopathy by percutaneous coronary transplantation of BMSCs, which can boost LVEF and improve cardiac function after transplantation.
背景：对于造血干细胞同种异体移植，当不能得到匹配的同胞供体时，一份库存的供体脐带血可能是很有价值的资源。
BACKGROUND: a stored cord blood donation may be a valuable source of hemopoietic stem cells for allogeneic transplantation when a matched sibling donor is not available.
结论 脐带间充质干细胞与脐血CD34+细胞共移植可促进造血干细胞的植入，缩短CD34+细胞移植后造血恢复时间。
Conclusion The co-transplantation of MSC cells and CD34+ cells can promote hematopoetic stem cell transplantation and hematopoetic recovery in vivo.
结论 脐带间充质干细胞与脐血CD34+细胞共移植可促进造血干细胞的植入，缩短CD34+细胞移植后造血恢复时间。
Conclusion The co-transplantation of MSC cells and CD34+ cells can promote hematopoetic stem cell transplantation and hematopoetic recovery in vivo.
应用推荐